Literature DB >> 26729012

Pulmonary toxoplasmosis in immunocompromised patients with interstitial pneumonia: a single-centre prospective study assessing PCR-based diagnosis.

Guillaume Desoubeaux1, Églantine Cabanne2, Claire Franck-Martel2, Martin Gombert2, Emmanuel Gyan3, Séverine Lissandre4, Marc Renaud4, Hélène Monjanel4, Caroline Dartigeas4, Éric Bailly2, Nathalie Van Langendonck2, Jacques Chandenier1.   

Abstract

AIMS: Pulmonary toxoplasmosis has become a very rare parasitic infection since the advent of highly active antiretroviral therapies. It is generally diagnosed by the direct microscopic observation of Toxoplasma gondii tachyzoites in bronchoalveolar lavage fluid (BALF). The aim of this study was to assess possible improvements in diagnostic performance associated with the use of real-time PCR.
METHODS: This prospective study was carried out on BALFs obtained from immunocompromised patients over a 2-year period. We systematically compared the results of conventional staining with those of molecular detection.
RESULTS: Two cases of pulmonary toxoplasmosis were diagnosed for a total of 336 samples. PCR did not detect any additional cases and was more time-consuming than conventional staining.
CONCLUSIONS: Conventional staining is a reliable technique and is probably the most appropriate method for experienced microbiology laboratories, whereas T. gondii-specific PCR may be useful for laboratories with less experience in parasitology. TRIAL REGISTRATION NUMBER: 2015_030, May 27th 2015. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  DIAGNOSIS; LUNG; PCR; SEROLOGY; TOXOPLASMA

Mesh:

Year:  2016        PMID: 26729012     DOI: 10.1136/jclinpath-2015-203385

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  3 in total

1.  Up-regulated TLR2 and TLR4 expressions in liver and spleen during acute murine T. gondii infection.

Authors:  Jialing Peng; Xiancan Lin; Hongchun Lin; Shengjie Chen; Jinfeng Liu; Zexin Guo; Yuqing Liang; Shiguang Huang; Fangli Lu
Journal:  Parasitol Res       Date:  2016-08-17       Impact factor: 2.289

2.  Ginger Is a Potential Therapeutic for Chronic Toxoplasmosis.

Authors:  Asmaa M El-Kady; Wafa Abdullah I Al-Megrin; Iman A M Abdel-Rahman; Eman Sayed; Eman Abdullah Alshehri; Majed H Wakid; Fadi M Baakdah; Khalil Mohamed; Hayam Elshazly; Hussah M Alobaid; Safa H Qahl; Hatem A Elshabrawy; Salwa S Younis
Journal:  Pathogens       Date:  2022-07-15

3.  Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.

Authors:  Florence Robert-Gangneux; Valeria Meroni; Damien Dupont; Françoise Botterel; José M Aguado Garcia; Marie-Pierre Brenier-Pinchart; Isabelle Accoceberry; Hamdi Akan; Isabella Abbate; Katia Boggian; Fabrizio Bruschi; Jordi Carratalà; Miruna David; Lubos Drgona; Olgica Djurković-Djaković; Maria Carmen Farinas; Francesca Genco; Effrossyni Gkrania-Klotsas; Andreas H Groll; Edward Guy; Cédric Hirzel; Nina Khanna; Özgür Kurt; Lia Monica Junie; Tiziana Lazzarotto; Oscar Len; Nicolas J Mueller; Patricia Munoz; Zoi Dorothea Pana; Emmanuel Roilides; Tijana Stajner; Christian van Delden; Isabelle Villena; Hervé Pelloux; Oriol Manuel
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.